Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
141
Recruiting, any sponsor type, condition "osteoarthritis"
By trial status
The same filters, counted in each status. Pick one to switch.
- Recruiting141
- Completed1,107
141 trials
Showing 1 to 25, recently updated first.
- Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisPivotal-lookingRecruiting
Medipost, Inc.Industry
NCT07339111 · 300 participants (planned) · Start Mar 11, 2026 · Primary completion Jun 30, 2029
Drug: CARTISTEM® + Debridement · For: Knee Cartilage Defects
Sites: Birmingham, Alabama; Scottsdale, Arizona; Tempe, Arizona · 40 sites in all
Sclnow Biotechnology Co., Ltd.Industry
NCT03383081 · 60 participants (planned) · Start Oct 1, 2018 · Primary completion Dec 31, 2026
Drug: Low dose mesenchymal stem cells; High dose mesenchymal stem cells · For: Osteoarthritis, Knee
Sites: Changsha, China
- Perioperative Vitamin C to Reduce Persistent Pain After Total Knee ArthroplastyPivotal-lookingRecruiting
University Health Network, TorontoAcademic, hospital or other
NCT06123715 · 3,216 participants (planned) · Start Apr 16, 2024 · Primary completion Dec 31, 2029
Drug: Vitamin C; Placebo · For: Chronic Pain; Knee Pain Chronic; Post Operative Pain and 1 more
Sites: Toronto, Canada · 3 sites in all
Poznan University of Medical SciencesAcademic, hospital or other
NCT07180979 · 90 participants (planned) · Start Sep 15, 2025 · Primary completion Sep 30, 2027
Drug: Ropivacaine 0.5% Injectable Solution; Ropivacaine 0.2% Injectable Solution and 1 more · For: Hip Osteoarthritis; Hip Arthropathy; Hip Pain Chronic
Sites: Poznan, Poland
- A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)Pivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07919678 · 656 participants (planned) · Start Oct 26, 2026 · Primary completion Aug 22, 2028
Drug: Berobenatide · For: Obesity; Overweight; Osteoarthritis of the Knee
Sites: Tempe, Arizona; Escondido, California; Rancho Cucamonga, California · 40 sites in all
Poznan University of Medical SciencesAcademic, hospital or other
NCT07584200 · 90 participants (planned) · Start May 7, 2026 · Primary completion Mar 31, 2027
Drug: Intrathecal Morphine; Dexamethasone · For: Arthropathy of Hip; Hip Osteoarthritis
Sites: Poznan, Poland
- ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee ArthroplastyPivotal-lookingRecruiting
Poznan University of Medical SciencesAcademic, hospital or other
NCT07677215 · 120 participants (planned) · Start May 20, 2026 · Primary completion Sep 1, 2027
Drug: Ropivacaine 0.2% Injectable Solution; Dexamethasone and 1 more · For: Knee Osteoarthritis
Sites: Lublin, Poland; Poznan, Poland
- Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip ArthroplastyPivotal-lookingRecruiting
Poznan University of Medical SciencesAcademic, hospital or other
NCT07581470 · 198 participants (planned) · Start May 8, 2026 · Primary completion Jun 30, 2027
Drug: Dexamethasone 4mg; Placebo and 1 more · For: Osteoarthritis, Hip; Hip Osteoarthritis
Sites: Poznan, Poland
- A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPivotal-lookingRecruiting
Eli Lilly and CompanyEli Lilly (LLY)
NCT05986292 · 10,000 participants (planned) · Start Jan 30, 2020 · Primary completion Apr 2027
Drug: LY3016859 ISA; LY3556050 ISA and 5 more · For: Osteoarthritis, Knee; Diabetic Neuropathic Pain; Chronic Low-back Pain
Sites: Birmingham, Alabama; Glendale, Arizona; Phoenix, Arizona · 64 sites in all
Poznan University of Medical SciencesAcademic, hospital or other
NCT07449442 · 60 participants (planned) · Start Mar 1, 2026 · Primary completion Nov 30, 2026
Drug: sodium Chloride; Ropivacaine Hydrocloride · For: Knee Osteoarthritis
Sites: Poznan, Poland
Poznan University of Medical SciencesAcademic, hospital or other
NCT07743853 · 90 participants (planned) · Start Aug 1, 2026 · Primary completion Nov 30, 2027
Drug: Placebo; Dexmedetomidine and 1 more · For: Hip Osteoarthritis
Sites: Poznan, Poland
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis PainPivotal-lookingRecruiting
Eli Lilly and CompanyEli Lilly (LLY)
NCT07641517 · 150 participants (planned) · Start Jun 25, 2026 · Primary completion Apr 2027
Drug: LY4065967; Placebo · For: Osteoarthritis, Knee; Chronic Pain
Sites: Birmingham, Alabama; Phoenix, Arizona; Palm Springs, California · 36 sites in all
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)Pivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07915609 · 756 participants (planned) · Start Oct 26, 2026 · Primary completion Aug 21, 2028
Drug: Berobenatide; Placebo · For: Obesity; Overweight and/or Obesity; Knee Osteoarthritis and 1 more
Sites: Birmingham, Alabama; Tucson, Arizona; Miami, Florida · 4 sites in all
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPivotal-lookingRecruiting
Eli Lilly and CompanyEli Lilly (LLY)
NCT07353931 · 900 participants (planned) · Start Feb 9, 2026 · Primary completion Mar 2028
Drug: Eloralintide; Placebo · For: Osteoarthritis; Overweight or Obesity
Sites: Mobile, Alabama; Mesa, Arizona; Phoenix, Arizona · 147 sites in all
- Exploration of Appropriate BIS Range and Propofol Effect-site Concentration During Total Intravenous Anesthesia With Concomitant Adjuvants.Pivotal-lookingRecruiting
China-Japan Friendship HospitalAcademic, hospital or other
NCT07736352 · 100 participants (planned) · Start Jul 30, 2026 · Primary completion Jan 31, 2027
Drug: Propofol + Remifentanil +Midazolam; Propofol + Remifentanil + Dexmedetomidine and 2 more · For: Knee Osteoarthritis; Replacement, Knee; Elective Surgical Patients and 1 more
Sites: Beijing, China
Anhui HygeianCells BioMedical Co., Ltd.Industry
NCT07902128 · 26 participants (planned) · Start Dec 10, 2025 · Primary completion Mar 2027
Drug: Animal early embryo extract · For: Knee Arthritis, Osteoarthritis
Sites: Huangshan City, China
- Autologous Adipose-Derived Stem Cell Injections for Knee OsteoarthritisPivotal-lookingRecruiting
Yonsei UniversityAcademic, hospital or other
NCT07901790 · 165 participants (planned) · Start Sep 3, 2026 · Primary completion Feb 29, 2028
Drug: Autologous Adipose-Derived Mesenchymal Stem Cells (ADMSCs); Cross-linked Hyaluronic Acid (Synovian) · For: Osteoarthritis; Knee; Knee Osteoarthritis
Sites: Incheon, South Korea; Seoul, South Korea · 3 sites in all
- Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKAPivotal-lookingRecruiting
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Academic, hospital or other
NCT07430085 · 150 participants (planned) · Start Sep 3, 2026 · Primary completion Jan 31, 2028
Drug: Bupivacaine; Ketorolac and 1 more · For: Periarticular Block; Osteoarthritis (OA); Osteoarthritis (OA) of the Knee and 2 more
Sites: Cranberry Township, Pennsylvania
Yonsei UniversityAcademic, hospital or other
NCT07898501 · 20 participants (planned) · Start Nov 1, 2026 · Primary completion Sep 30, 2028
Drug: Autologous adipose-derived stromal vascular fraction intra-articular injection · For: Osteoarthritis, Knee
Sites: Seoul, South Korea
Benedict AlterAcademic, hospital or other
NCT07759336 · 85 participants (planned) · Start Sep 15, 2026 · Primary completion Dec 2028
Drug: Duloxetine; Placebo · For: Knee Osteoarthritis (Knee OA); Chronic Pain; Chronic Knee Pain
Sites: Pittsburgh, Pennsylvania
Avidence TherapeuticsIndustry
NCT07338266 · 20 participants (planned) · Start Jan 22, 2026 · Primary completion May 2027
Drug: AVD275 Intra-articular Injection · For: Osteoarthritis of the Knee
Sites: Wahroonga, Australia
- A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)Pivotal-lookingRecruiting
Doron Therapeutics Inc.Industry
NCT07219771 · 300 participants (planned) · Start Oct 14, 2025 · Primary completion Jun 30, 2027
Drug: PTP-01 · For: Knee Osteoarthritis
Sites: Birmingham, Alabama; Tucson, Arizona; La Mesa, California · 18 sites in all
The Foundation for Orthopaedics and Regenerative MedicineAcademic, hospital or other
NCT05147675 · 92 participants (planned) · Start Dec 1, 2022 · Primary completion Dec 1, 2027
Drug: AlloRx · For: Osteoarthritis; Spinal Arthritis
Sites: Naples, Florida; Athens, Greece
- Preventing Injured Knees From osteoArthritis: Severity OutcomesPivotal-lookingRecruiting
Brigham and Women's HospitalAcademic, hospital or other
NCT06096259 · 512 participants (planned) · Start May 6, 2024 · Primary completion Dec 2029
Drug: Metformin; Placebo · For: Osteoarthritis, Knee; Post-traumatic Osteoarthritis; ACL Tear
Sites: Atlanta, Georgia; Iowa City, Iowa; Lexington, Kentucky · 9 sites in all
- Intra-Articular Allocetra in Patients With Primary Knee OsteoarthritisPivotal-lookingRecruiting
Enlivex Therapeutics Ltd.Industry
NCT07580716 · 182 participants (planned) · Start May 1, 2026 · Primary completion Feb 2027
Drug: Allocetra · For: Primary Knee Osteoarthritis
Sites: Longwood, Florida; Miami, Florida; New Orleans, Louisiana · 17 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.